menu
    • menu

    Company profile for Artelo Biosciences

    NEW Drugs in Dev: 4
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Artelo Biosciences is a biopharmaceutical company dedicated to applying true biopharma discipline in leveraging past research and leading-edge, world-class science to accelerate the development and commercialization of a diverse portfolio of novel, endocannabinoid system modulating therapeutics. Our programs have the potential to dramatically improve patient care in major markets. We expect to deliver on the promise of new med...
    Artelo Biosciences is a biopharmaceutical company dedicated to applying true biopharma discipline in leveraging past research and leading-edge, world-class science to accelerate the development and commercialization of a diverse portfolio of novel, endocannabinoid system modulating therapeutics. Our programs have the potential to dramatically improve patient care in major markets. We expect to deliver on the promise of new medicines to treat a wide range of diseases and conditions for patients in need of better outcomes. By doing so, we will create value for patients, physicians, and our investors.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Artelo BiosciencesUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    888 Prospect Street, Suite 210 La Jolla, CA. 92037
    Telephone
    Telephone
    (760) 943-1689
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://artelobio.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/artelo-biosciences-inc/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/ArteloBio

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    AMWC Asia-TDAC

    AMWC Asia-TDAC

    Not Confirmed

    envelop Contact Supplier

    AMWC Asia-TDAC

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Artelo Partners with ScienceMachine to Advance FABP5 Inhibitor
    Artelo Partners with ScienceMachine to Advance FABP5 Inhibitor

    28 Apr 2026

    // FIRSTWORD PHARMA

    https://firstwordpharma.com/story/7232491

    FIRSTWORD PHARMA
    28 Apr 2026
    Share Share
    Artelo Bio Regains Compliance with Nasdaq Listing Requirements
    Artelo Bio Regains Compliance with Nasdaq Listing Requirements

    07 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/07/3269024/0/en/Artelo-Biosciences-Regains-Compliance-with-Nasdaq-Listing-Requirements.html

    GLOBENEWSWIRE
    07 Apr 2026
    Share Share
    Artelo Bio Closes $11M Private Placement Under Nasdaq Rules
    Artelo Bio Closes $11M Private Placement Under Nasdaq Rules

    30 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/30/3265050/0/en/Artelo-Biosciences-Announces-Closing-of-11-0-Million-Private-Placement-Priced-At-the-Market-Under-Nasdaq-Rules.html

    GLOBENEWSWIRE
    30 Mar 2026
    Share Share
    Artelo Bio Announces $11.0M Private Placement Under Nasdaq Rules
    Artelo Bio Announces $11.0M Private Placement Under Nasdaq Rules

    27 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/27/3263855/0/en/Artelo-Biosciences-Announces-11-0-Million-Private-Placement-Priced-At-the-Market-Under-Nasdaq-Rules.html

    GLOBENEWSWIRE
    27 Mar 2026
    Share Share
    Artelo Expands ART27.13 For GLP-1 Treatment Companion Therapy
    Artelo Expands ART27.13 For GLP-1 Treatment Companion Therapy

    25 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/25/3262568/0/en/Artelo-Biosciences-Expands-ART27-13-Development-as-a-Potential-Companion-Therapy-to-GLP-1-Treatments.html

    GLOBENEWSWIRE
    25 Mar 2026
    Share Share
    Artelo Biosciences, Fully Funded, Enters $16.3B Glaucoma Market
    Artelo Biosciences, Fully Funded, Enters $16.3B Glaucoma Market

    25 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/25/3262098/0/en/Artelo-Biosciences-Expansion-into-16-3B-Glaucoma-Market-Via-Fully-Funded-Study-Highlights-Multi-Platform-Pipeline-Strength.html

    GLOBENEWSWIRE
    25 Mar 2026
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search